CluePoints

Activities: Regulatory

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Digital

CluePoints wins SCRIP award for best contract research organisation (CRO): specialist providers

Company wins prestigious accolade for commitment to innovation and education
Manufacturing

CluePoints’ RBQM platform used to support COVID-19 trials

The RBQM platform is used to detect and monitor potential risks allowing corrective action to be taken. Teams can access information centrally, collaborate and document mitigations and remedial actions to produce a clean data set and prepare for the usual regulatory scrutiny
Manufacturing

Parexel and CluePoints join forces

Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs
Regulatory

CluePoint champions risk-based study execution

Increased operational efficiency, lower costs and reduced regulatory submission risk are all part of the touted benefits of the industry paradigm shift to RBx
Recruitment

CluePoints strengthens team with two appointments
Regulatory

CluePoints launches risk-based monitoring starter pack

CluePoints, provider of risk-based monitoring (RBM) and data quality oversight solutions for clinical trials, has launched the “CluePoints RBM and ICH E6 (R2) Starter Pack” to help small and medium-sized enterprises (SMEs) achieve regulatory compliance through a risk-based approach
Media

CluePoints responds to sponsor and CRO demand with two new appointments
Subscribe now